Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma

Condition:   Sarcoma Intervention:   Drug: Anlotinib+ Liposomal Doxorubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Beijing Cancer Hospital;   Tianjin Medical University Cancer Institute and Hospital;   First Hospital of Jilin University;   Hunan Cancer Hospital;   Ruijin Hospital;   Liaoning Tumor Hospital & Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials